Skip to main content
. 2021 Jun 24;13(12):16713–16732. doi: 10.18632/aging.203190

Figure 5.

Figure 5

Tumor-infiltrating immune cells (TIICs) analysis of 243 endometrial cancer (EC) patients (133 low-risk patients and 110 high-risk patients) (CIBERSORT: P < 0.05). (A, B) Composition of 22 TIICs. (C) Wilcoxon test analysis of 22 TIICs between low- and high-risk EC patients. (D, E) Single-sample gene set enrichment analysis (ssGSEA) of specific immune cells and immune functions (*p < 0.05; **p < 0.01; ***p < 0.001).